Yokohama, Japan

Takeshi Uchida


Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Yokohama, JP (1985 - 1986)
  • Takasaki, JP (1987)

Company Filing History:


Years Active: 1985-1987

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Takeshi Uchida

Introduction

Takeshi Uchida is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of microbial chemistry, particularly in the development of novel physiologically active substances. With a total of 3 patents to his name, Uchida's work has had a considerable impact on pharmaceutical applications.

Latest Patents

Uchida's latest patents include a novel physiologically active substance known as MH435. This substance is represented by a specific chemical formula, wherein R can be either of two groups. Another notable patent is for Serirubicum, an anthracycline compound produced through the cultivation of a specific strain of Streptomyces. This process allows for the recovery of serirubicin, which can be used as an active ingredient in anti-tumor agents and pharmaceutical compositions aimed at treating infections caused by gram-positive microorganisms.

Career Highlights

Uchida is affiliated with the Microbial Chemistry Research Foundation, where he continues to advance research in his field. His innovative work has garnered attention and respect within the scientific community, contributing to the development of effective treatments for various medical conditions.

Collaborations

Uchida has collaborated with notable colleagues, including Hamao Umezawa and Tomio Takeuchi. These partnerships have further enhanced the scope and impact of his research endeavors.

Conclusion

Takeshi Uchida's contributions to microbial chemistry and his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of important pharmaceutical agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…